• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor.

作者信息

Jenster G, van der Korput H A, Trapman J, Brinkmann A O

机构信息

Department of Endocrinology, Erasmus University Rotterdam, The Netherlands.

出版信息

J Biol Chem. 1995 Mar 31;270(13):7341-6. doi: 10.1074/jbc.270.13.7341.

DOI:10.1074/jbc.270.13.7341
PMID:7706276
Abstract

To locate in detail the regions in the human androgen receptor (AR) involved in transcription activation, a series of N-terminal deletions was introduced in the wild type AR and in a constitutively active AR. The different constructs were tested for their capacity to activate transcription. Almost the entire N-terminal domain (residues 1-485) was necessary for full wild type AR activity when cotransfected with the (GRE)2tkCAT reporter in HeLa cells. In contrast, a smaller part of the N-terminal domain (amino acids 360-528) was sufficient for the constitutively active AR to induce transcription of the same (GRE)2tkCAT reporter in HeLa cells. This demonstrates the capacity of the AR to use different regions in the N-terminal domain as transcription activation units (TAUs). To obtain additional information of AR N-terminal TAUs, the GAL4 DNA binding domain was linked to either the entire or parts of the AR N-terminal domain and cotransfected with the (UAS)2tkCAT reporter in HeLa cells. The results confirmed that the first 485 amino acid residues accommodate a transcription activation function. When the chimeric AR-GAL4 constructs were tested on a different reporter ((UAS)5E1bCAT), a small shift in position of the TAU, responsible for full transcription activation, was observed. The data presented show that the size and location of the active TAU in the human AR is variable, being dependent on the promoter context and the presence or absence of the ligand binding domain.

摘要

相似文献

1
Identification of two transcription activation units in the N-terminal domain of the human androgen receptor.
J Biol Chem. 1995 Mar 31;270(13):7341-6. doi: 10.1074/jbc.270.13.7341.
2
Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.雄激素受体氨基末端、反式激活结构域与配体结合结构域之间的体内功能相互作用。
Biochemistry. 1997 Feb 4;36(5):1052-64. doi: 10.1021/bi961775g.
3
Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.配体激活的人雄激素受体二聚体反平行取向的证据。
J Biol Chem. 1995 Dec 15;270(50):29983-90. doi: 10.1074/jbc.270.50.29983.
4
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization.人类雄激素受体中参与类固醇结合、转录激活和亚细胞定位的结构域。
Mol Endocrinol. 1991 Oct;5(10):1396-404. doi: 10.1210/mend-5-10-1396.
5
Constitutively active human Notch1 binds to the transcription factor CBF1 and stimulates transcription through a promoter containing a CBF1-responsive element.组成型激活的人类Notch1与转录因子CBF1结合,并通过含有CBF1反应元件的启动子刺激转录。
Proc Natl Acad Sci U S A. 1996 May 28;93(11):5663-7. doi: 10.1073/pnas.93.11.5663.
6
Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.肺泡横纹肌肉瘤中染色体易位导致转录功能获得的机制。
Proc Natl Acad Sci U S A. 1996 May 28;93(11):5455-9. doi: 10.1073/pnas.93.11.5455.
7
Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.维斯纳病毒Tat蛋白:一种具有激活域和抑制域的强效转录因子。
J Virol. 1994 Oct;68(10):6137-46. doi: 10.1128/JVI.68.10.6137-6146.1994.
8
Functional domains of the human androgen receptor.人类雄激素受体的功能结构域。
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):671-5. doi: 10.1016/0960-0760(92)90402-5.
9
A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP.在单链结合蛋白FBP的羧基末端结构域中发现了一个独特的反式激活序列基序。
Mol Cell Biol. 1996 May;16(5):2274-82. doi: 10.1128/MCB.16.5.2274.
10
Transcriptional activation and transient expression of the human androgen receptor.人类雄激素受体的转录激活与瞬时表达
J Steroid Biochem Mol Biol. 1996 Sep;59(1):9-20. doi: 10.1016/s0960-0760(96)00097-0.

引用本文的文献

1
FMNL2/SRC-mediated androgen receptor translocation into the nucleus promotes enzalutamide resistance of prostate cancer.FMNL2/SRC介导的雄激素受体易位至细胞核促进前列腺癌对恩杂鲁胺的耐药性。
iScience. 2025 Mar 12;28(4):112205. doi: 10.1016/j.isci.2025.112205. eCollection 2025 Apr 18.
2
The androgen receptor amino-terminal domain: structure, function and therapeutic potential.雄激素受体氨基末端结构域:结构、功能及治疗潜力
Endocr Oncol. 2025 Feb 19;5(1):e240061. doi: 10.1530/EO-24-0061. eCollection 2025 Jan.
3
Phase Separation Mediated Sub-Nuclear Compartmentalization of Androgen Receptors.
相分离介导的雄激素受体亚核区室化。
Cells. 2024 Oct 13;13(20):1693. doi: 10.3390/cells13201693.
4
N-terminal domain of androgen receptor is a major therapeutic barrier and potential pharmacological target for treating castration resistant prostate cancer: a comprehensive review.雄激素受体的N端结构域是治疗去势抵抗性前列腺癌的主要治疗障碍和潜在药理学靶点:一篇综述
Front Pharmacol. 2024 Sep 18;15:1451957. doi: 10.3389/fphar.2024.1451957. eCollection 2024.
5
Inhibitors of the transactivation domain of androgen receptor as a therapy for prostate cancer.雄激素受体转录激活结构域抑制剂作为前列腺癌的治疗方法。
Steroids. 2024 Oct;210:109482. doi: 10.1016/j.steroids.2024.109482. Epub 2024 Jul 23.
6
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer.针对乳腺癌中雄激素受体及其剪接变体的治疗方法。
Int J Mol Sci. 2024 Feb 2;25(3):1817. doi: 10.3390/ijms25031817.
7
Synthesis and Evaluation of Small Molecule Inhibitors of the Androgen Receptor N-Terminal Domain.雄激素受体N端结构域小分子抑制剂的合成与评价
ACS Med Chem Lett. 2023 Nov 17;14(12):1800-1806. doi: 10.1021/acsmedchemlett.3c00426. eCollection 2023 Dec 14.
8
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.国际基础与临床药理学联盟第十三分会:核受体超家族-2023 更新。
Pharmacol Rev. 2023 Nov;75(6):1233-1318. doi: 10.1124/pharmrev.121.000436. Epub 2023 Aug 16.
9
Targeting the Androgen Signaling Axis in Prostate Cancer.靶向前列腺癌的雄激素信号通路。
J Clin Oncol. 2023 Sep 10;41(26):4267-4278. doi: 10.1200/JCO.23.00433. Epub 2023 Jul 10.
10
Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.揭开核受体在食管癌中功能作用的神秘面纱。
Int J Mol Sci. 2022 Sep 19;23(18):10952. doi: 10.3390/ijms231810952.